bpc 157 adverse event case report BPC-157 Side Effects: What Research Shows Why researchers are paying attention
Description
Zhu JR, Bai J, Cai NS, Tang B, Fan WH, Guo JZ,
There is a further complication
Dysesthesia The TRIUMPH-4 trial data revealed a notable safety signal: dysesthesia (abnormal sensations like tingling, burning, or numbness) was reported in 8.8% of participants on the 9 mg dose and 20.9% on the 12 mg dose of retatrutide
D.RegierJ
